Nanosponges harvest rare cancer marker from blood

Jan 19, 2011

Cancer researchers have long hypothesized that tumors release small amounts of proteins that could serve as earlier diagnostic indicators of cancer, but the search for such biomarkers has been hampered by the presence of large quantities of other proteins, such albumin, found in the blood and by the fact that these trace proteins are often unstable in blood. Now, an international research team from the United States and Italy has shown that it can use a new type of nanoparticle to selectively trap specific families of proteins from blood and protect them from degradation by enzymes in blood.

Lance Liotta of George Mason University and Caterina Longo from the University of Moderna and Regio Emilia led this investigation. The U.S. and Italian team published its findings in the journal Experimental Dermatology.

Previously, this research team had developed a set of highly porous nanoparticles whose interiors were decorated with different types of "bait" molecules that could selectively harvest large families of low-abundance proteins from blood. These nanoparticles were designed to exclude the relatively large protein-degrading enzymes prevalent in blood, and hence, could protect the trapped proteins from being broken down before they could be analyzed. In this set of experiments, the investigators used the particles to collect potential biomarkers for from the blood of human patients with this aggressive form of . The researchers obtained blood from 29 patients with primary and as well as 26 patients with strange-looking moles that had not developed into melanomas.

The researchers found that levels of one particular , known as Bak, correlated highly with the development of moles into melanomas. These results were confirmed by histological examination of moles and melanoma tumors. The investigators note that although more patients need to be tested to confirm these results, it appears that serum Bak levels, measured after capture using these nanoparticles, could serve as a prognostic indicator for melanoma. The broader impact of this study lies with the demonstration that these baited can trap and protect rare proteins in human clinical blood samples and release those proteins for subsequent analysis for disease .

This work, which was supported in part by the National Cancer Institute, is detailed in a paper titled, "A novel biomarker harvesting nanotechnology identifies Bak as a candidate melanoma biomarker in serum." An abstract of this paper is available through PubMed.

Explore further: Surprise: Biological microstructures light up after heating

More information: View the complete abstract here: www.ncbi.nlm.nih.gov/pubmed/21158936

Related Stories

New strategy developed to diagnose melanoma

Mar 30, 2009

A UCSF research team has developed a technique to distinguish benign moles from malignant melanomas by measuring differences in levels of genetic markers. Standard microscopic examinations of biopsied tissue can be ambiguous ...

New biomarkers for predicting the spread of colon cancer

Jan 13, 2010

Scientists in China are reporting discovery of two proteins present in the blood, of people with colon cancer that may serve as the potential biomarkers for accurately predicting whether the disease will spread. ...

Scientists improve biomarker detection technique

Sep 02, 2010

Scientists from NPL's Biotechnology group have developed a new strategy to enable quicker and more precise detection of biomarkers - proteins which indicate disease. The work marks a new research direction ...

Recommended for you

Light pulses control graphene's electrical behavior

20 hours ago

Graphene, an ultrathin form of carbon with exceptional electrical, optical, and mechanical properties, has become a focus of research on a variety of potential uses. Now researchers at MIT have found a way to control how ...

User comments : 0